Safety, PK, and PD Comparison of UI059 and UIC202201 in Healthy Volunteers

NCT07727629 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastro Esophageal Reflux Disorder

Interventions

DRUG: UI059
DRUG: UIC202201

Sponsor

Korea United Pharm. Inc.